Latest Capital Raises News

Oldfields Holdings Limited remains suspended from ASX trading following its failure to lodge critical half-year financial reports after announcing a capital raising.

Nagambie Resources has opened a discounted Share Purchase Plan aiming to raise $3.7 million to support diamond drilling at its Whroo Mines project and bolster working capital, following a strategic joint venture announcement with Alkane Resources.

Findi Limited has raised A$25 million through an institutional placement to refinance its Indian subsidiary’s balance sheet, reduce debt, and accelerate its ATM rollout and digital payments growth.

Cosmos Exploration Limited has voluntarily suspended its shares from ASX trading as it prepares to announce significant developments involving an Option Agreement and a capital Placement.

Rincon Resources has successfully raised $3.1 million to fund an expanded drilling campaign at its promising Telfer South Gold-Copper Project, following the discovery of a significantly larger mineralised zone at the Hasties Prospect.

Catalina Resources has reported a significant gold discovery at its Yerilgee Project in Western Australia, intersecting 48 metres at 2.61 grams per tonne from just 15 metres depth. This initial assay confirms a robust mineralised system with a high-grade core, setting the stage for further exploration.

Australian Bond Exchange Holdings has completed a $0.98 million placement and is proposing attaching options to raise additional funds, pending shareholder approval.

Elixir Energy has reached a key milestone by drilling and casing the heel of its Lorelle-3H well in Queensland’s Taroom Trough, setting the stage for horizontal drilling aimed at unlocking commercial gas flow.

Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.

Magellan Financial Group has announced a landmark merger with Barrenjoey Capital Partners, creating a diversified financial powerhouse valued at over A$1.6 billion. The deal includes a significant share placement and board reshuffle, setting the stage for expanded market influence.

Small caps stole the week, led by a big funding deal in gold and two revenue breakouts. Meanwhile, some well-known names slid after profit updates failed to calm nerves on costs and outlooks.